Prevalence of hypersexual behavior in Parkinson’s disease patients: Not restricted to males and dopamine agonist use

Christine A Cooper, Armon Jadidian, Michelle Paggi, Janet Romrell, Michael S Okun, et alDepartment of Neurology, University of Florida, Gainesville, FL, USAAbstract: This study investigates the prevalence and demographic characteristics of hypersexuality in Parkinson’s disease (PD). Im...

Full description

Bibliographic Details
Main Authors: Christine A Cooper, Armon Jadidian, Michelle Paggi, Janet Romrell, Michael S Okun, et al
Format: Article
Language:English
Published: Dove Medical Press 2009-03-01
Series:International Journal of General Medicine
Online Access:http://www.dovepress.com/prevalence-of-hypersexual-behavior-in-parkinsonrsquos-disease-patients-a2985
Description
Summary:Christine A Cooper, Armon Jadidian, Michelle Paggi, Janet Romrell, Michael S Okun, et alDepartment of Neurology, University of Florida, Gainesville, FL, USAAbstract: This study investigates the prevalence and demographic characteristics of hypersexuality in Parkinson’s disease (PD). Impulse control disorders in PD patients have been associated with dopamine agonist therapy. Moreover, hypersexuality and pathological gambling have been associated with males, while females may be inherently thought to be more likely to participate in compulsive shopping and binge-eating behaviors. In this study, a screening mail-in survey was sent to all PD patients at a single Movement Disorders Center. One  hundred forty one of 400 (35.3%) research packets were returned completed. Fifteen of 141 patients met initial screening criteria for hypersexual behavior. After detailed interview, only 6/141 (4.3%) of PD patients met criteria for pathologic hypersexual behavior. These behaviors included: compulsive masturbation, prostitution, and paraphilias. Patients with a younger age of PD onset were more likely to exhibit hypersexual behavior. Unlike previous report, no significant association was found between hypersexuality and gender or dopamine agonist use. Rather, this study suggests that physicians should be vigilant for hypersexual behavior in all PD patients, regardless of gender and PD medication regimen. Ultimately, given the innate sensitivity of the topic and survey limitations, it is very likely that hypersexual behavior in our cohort, as it is in the general PD population, has been under-reported.Keywords: Parkinson’s disease, hypersexuality, impulsive behavior, dopamine agonists
ISSN:1178-7074